ScienceDex / Researcher record
Pagadala, Vijayakanth
- Glycan Therapeutics Corporation (no department on record)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
NIH Funding · FY2019
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $952,831 | 1 | #7,351 |
| 2017 | $693,710 | 1 | #11,424 |
| 2019 | $1,781,203 | 2 | #3,738 |
| 2021 | $1,773,138 | 3 | #4,117 |
| 2023 | $355,989 | 1 | #32,471 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20151 record
- FY20171 record
- FY2019 · selected2 records
- FY20213 records
- FY20231 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award records by amount
NIH award records listing Pagadala, Vijayakanth as a PI. Multi-PI records show the full award amount for context.
- 2R44HL139187-02R44Contact PIDevelopment of a New Carbohydrate-based Anticoagulant Drug$1.2Maward amount
- 1R44GM134738-01R44Contact PIDiverse Heparan Sulfate Oligosaccharide Libraries For Understanding and Therapeutically Manipulating Glycosaminoglycans$536.8Kaward amount
Award organization
Organizations that administered FY2019 awards listing Pagadala, Vijayakanth as a PI.
FY2019 award administered by Glycan Therapeutics Corporation (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardGlycan Therapeutics Corporation
- 2015$500K Cumulative Funding
- 2015Entered Top 50% NationallyRanked #7351
- 2017$1M Cumulative Funding
- 2019$2M Cumulative Funding
- 2019Entered Top 25% NationallyRanked #3738
- 2021$5M Cumulative Funding